The significance of FSP1 in regulating ferroptosis and the possibility of targeting FSP1 as a potential sensitizing strategy have recently attracted increasing interest, as exemplified by a number of studies demonstrating FSP1-mediated ferroptosis-resistance to therapy in models of KEAP1 and KRAS mutant lung cancers [19, 20]. Here, AIFM2 is linked to lung carcinoma.